These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 15347138)

  • 1. Hybrid alpha/beta3-peptides with proteinogenic side chains. Monosubstituted analogues of the chemotactic tripeptide For-Met-Leu-Phe-OMe.
    Giordano C; Lucente G; Mollica A; Nalli M; Pagani Zecchini G; Paglialunga Paradisi M; Gavuzzo E; Mazza F; Spisani S
    J Pept Sci; 2004 Aug; 10(8):510-23. PubMed ID: 15347138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, conformation, and activity of HCO-Met-delta Z Leu-Phe-OMe, an active analogue of chemotactic N-formyltripeptides.
    Pagani Zecchini G; Paglialunga Paradisi M; Torrini I; Lucente G; Gavuzzo E; Mazza F; Pochetti G; Paci M; Sette M; Di Nola A
    Biopolymers; 1993 Mar; 33(3):437-51. PubMed ID: 8461452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic formyl tripeptide chemoattractants: a C(alpha,alpha)-dialkylated, amphiphilic glycyl residue at position 1.
    Witkowska R; Zabrocki J; Spisani S; Falzarano MS; Toniolo C; Formaggio F
    J Pept Sci; 2003 Jun; 9(6):354-60. PubMed ID: 12846481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and properties of chemotactic peptide analogs. II. HCO-Met-Leu-Phe-OMe analogs containing cyclic alpha,alpha-disubstituted amino acids as Met and Phe mimicking residues.
    Torrini I; Pagani Zecchini G; Paglialunga Paradisi M; Lucente G; Gavuzzo E; Mazza F; Pochetti G; Spisani S; Giuliani AL
    Int J Pept Protein Res; 1991 Dec; 38(6):495-504. PubMed ID: 1668096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, conformation and biological activity of centrally modified pseudopeptidic analogues of For-Met-Leu-Phe-OMe.
    Giordano C; Lucente G; Masi A; Paglialunga Paradisi M; Sansone A; Spisani S
    Amino Acids; 2007 Sep; 33(3):477-87. PubMed ID: 17021652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hybrid alpha/beta-peptides: for-Met-Leu-Phe-OMe analogues containing geminally disubstituted beta2,2- and beta 3,3-amino acids at the central position.
    Mollica A; Paglialunga Paradisi M; Torino D; Spisani S; Lucente G
    Amino Acids; 2006 Jun; 30(4):453-9. PubMed ID: 16547648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The importance of the peptide bond at position 2 in HCO-Met-Leu-Phe-OMe analogues as shown by studies on human neutrophils.
    Cavicchioni G; Breveglieri A; Boggian M; Vertuani G; Reali E; Spisani S
    J Pept Sci; 1996; 2(3):135-40. PubMed ID: 9231322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of new active For-Met-Leu-Phe-OMe analogues containing para-substituted Phe residues.
    Mollica A; Feliciani F; Stefanucci A; Costante R; Lucente G; Pinnen F; Notaristefano D; Spisani S
    J Pept Sci; 2012 Jun; 18(6):418-26. PubMed ID: 22528501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isopeptide bonds in chemotactic tripeptides. Synthesis and activity of lysine-containing fMLF analogs.
    Pagani Zecchini G; Nalli M; Mollica A; Lucente G; Paglialunga Paradisi M; Spisani S
    J Pept Res; 2002 Jun; 59(6):283-91. PubMed ID: 12010519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and bioactivity of chemotactic tetrapeptides: fMLF-OMe analogues incorporating spacer aminoacids at the lateral positions.
    Lucente G; Giordano C; Sansone A; Torino D; Spisani S
    Amino Acids; 2009 Jul; 37(2):285-95. PubMed ID: 18636221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel chemotactic For-Met-Leu-Phe-OMe (fMLF-OMe) analogues based on met residue replacement by 4-amino-proline scaffold: synthesis and bioactivity.
    Torino D; Mollica A; Pinnen F; Feliciani F; Spisani S; Lucente G
    Bioorg Med Chem; 2009 Jan; 17(1):251-9. PubMed ID: 19081258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, conformation, and biological activity of two fMLP-OMe analogues containing the new 2-[2'-(methylthio)ethyl]methionine residue.
    Torrini I; Paglialunga Paradisi M; Pagani Zecchini G; Lucente G; Gavuzzo E; Mazza F; Pochetti G; Traniello S; Spisani S
    Biopolymers; 1997 Oct; 42(4):415-26. PubMed ID: 9283291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, biological activity and conformational studies of geometrically restricted tripeptide analogues of the chemoattractant HCO-Met-Leu-Phe-OMe.
    Boggian M; Vertuani G; Cavicchioni G; Pecoraro R; Scatturin A; Spisani S
    Farmaco; 1997; 52(6-7):439-44. PubMed ID: 9372595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conformationally constrained formyl methionyl tripeptides: structure-function study of analogs containing alpha,beta-dehydrophenylalanine and dehydroleucine.
    Bharadwaj A; Singh M; Bhandary K; Becker EL; Chauhan VS
    Pept Res; 1993; 6(6):298-307. PubMed ID: 8292847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modified chemotactic peptides: synthesis, crystal conformation, and activity of For-Hse(Me)-Leu-Phe-OMe.
    Torrini I; Pagani Zecchini G; Paglialunga Paradisi M; Lucente G; Gavuzzo E; Mazza F; Pochetti G; Traniello S; Spisani S
    Biopolymers; 1994 Jan; 34(1):1-9. PubMed ID: 8110962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. For-Met-Lys-Phe-For-Met-Lys-Phe-: a new cyclic analogue of the chemotactic formylpeptides.
    Torrini I; Zecchini GP; Paradisi MP; Lucente G; Gavuzzo E; Mazza F; Pochetti G; Traniello S; Spisani S
    Biopolymers; 1995 Apr; 35(4):347-58. PubMed ID: 7711275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modified chemotactic peptides: synthesis and biological activity of HCO-Met-delta ZLeu-delta ZPhe-OMe.
    Pagani Zecchini G; Torrini I; Paglialunga Paradisi M; Lucente G; Spisani S
    Farmaco; 1994 Nov; 40(11):739-42. PubMed ID: 7832975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformationally restricted formyl methionyl tripeptide chemoattractants: a three-dimensional structure-activity study of analogs incorporating a C alpha,alpha-dialkylated glycine at position 2.
    Toniolo C; Crisma M; Valle G; Bonora GM; Polinelli S; Becker EL; Freer RJ; Sudhanand ; Rao RB; Balaram P
    Pept Res; 1989; 2(4):275-81. PubMed ID: 2520765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modified chemotactic peptides: synthesis, conformation, and biological activity of For-Thp-Leu-delta ZPhe-OMe.
    Torrini I; Zecchini GP; Paglialunga Paradisi M; Lucente G; Gavuzzo E; Mazza F; Pochetti G; Traniello S; Spisani S; Cerichelli G
    Biopolymers; 1994 Oct; 34(10):1291-302. PubMed ID: 7948717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New chemotactic dimeric peptides show high affinity and potency at the human formylpeptide receptor.
    Spisani S; Fraulini A; Varani K; Falzarano S; Cavicchioni G
    Eur J Pharmacol; 2007 Jul; 567(1-2):171-6. PubMed ID: 17481605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.